Precision Biosciences (DTIL) Other Accumulated Expenses (2019 - 2026)

Precision Biosciences (DTIL) has 8 years of Other Accumulated Expenses data on file, last reported at $858000.0 in Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $858000.0, down 4.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $858000.0 (down 4.24% YoY), and the FY2025 annual result was $649000.0, down 34.38% from the prior year.
• Other Accumulated Expenses improved to $858000.0 in Q1 2026 per DTIL's latest filing, from $649000.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $2.8 million in Q1 2024 and troughed at $611000.0 in Q3 2025.
• A 5-year average of $1.3 million and a median of $1.2 million in 2022 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2023 and 2025: Other Accumulated Expenses surged 220.94% in 2023, then tumbled 67.68% in 2025.
• A 5-year view of Other Accumulated Expenses shows it stood at $745000.0 in 2022, then surged by 220.94% to $2.4 million in 2023, then tumbled by 58.64% to $989000.0 in 2024, then sank by 34.38% to $649000.0 in 2025, then surged by 32.2% to $858000.0 in 2026.
• Business Quant data shows DTIL's Other Accumulated Expenses at $858000.0 in Q1 2026, $649000.0 in Q4 2025, and $611000.0 in Q3 2025.